Author

Fadi Ghantous

Beth Israel Deaconess Medical CenterORCID 0000-0002-6772-6901Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein design· 1 Assay:proteomics· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Aaron W. KollaschiD· 1 shared Adrian R. LaciakiD· 1 shared Alec W. FreyniD· 1 shared Alexander A. CoheniD· 1 shared Amy C ShermaniD· 1 shared Amy Gorrie· 1 shared Andrea Carfı́iD· 1 shared Ann DauphiniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aaron W. KollaschORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 16, 2025

mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize contemporary JN.1-lineage viruses

Arshan Nasir, Diana Wing Lee, Ziqiu Wang…·Alec W. Freyn

This study develops and evaluates two mRNA vaccines targeting the LP.8.1 variant of SARS-CoV-2, showing broad neutralization against JN.1-lineage subvariants.

1 citation

mouseexperimental assay

𝕏 PostBluesky

ImmunologyImmunityPeer-reviewedMay 8, 2025

Protein design for evaluating vaccines against future viral variation

Noor Youssef, Sarah F. Gurev, Fadi Ghantous…·Debora S. Marks

The paper designs SARS-CoV-2 Spike proteins with novel mutations to evaluate vaccine effectiveness against future viral variants using a deep learning model.

36 citationstop 1%

humanproteomics

𝕏 PostBluesky